New Obesity Drug Results
3:22–4:19 · 57s
Eli Lilly reveals trial data showing patients lost up to 56 pounds on retatrutide, but FDA submission slips to 2027.
3:22–4:19 · 57s
Eli Lilly reveals trial data showing patients lost up to 56 pounds on retatrutide, but FDA submission slips to 2027.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.